# OnCo record paper-cart19-be-01-mol-ther-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cart19-be-01-mol-ther-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cart19-be-01-mol-ther-2021" ;
  schema:name "CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19(+) Relapsed/Refractory Malignancies"@en ;
  schema:description "The results of the academic CAR-T trial that Spain's regulator used to authorise a hospital-made cell therapy for adult leukaemia, which the AEMPS described as the first CAR-T developed entirely in Europe to be approved by a regulator."@en ;
  schema:url <https://onco.cc/key-papers/paper-cart19-be-01-mol-ther-2021/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ymthe.2020.09.027>, <https://pubmed.ncbi.nlm.nih.gov/33010231/> ;
  schema:sameAs <https://doi.org/10.1016/j.ymthe.2020.09.027> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Ortíz-Maldonado V, Rives S, Castellà M, et al." ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/varnimcabtagene-autoleucel/> ;
  onco:institutions <https://onco.cc/institutions/hospital-clinic-barcelona/>, <https://onco.cc/institutions/ciberonc/> ;
  onco:trials <https://onco.cc/trials/cart19-be-01/> ;
  onco:people <https://onco.cc/people/valentin-ortiz-maldonado/>, <https://onco.cc/people/julio-delgado/>, <https://onco.cc/people/manel-juan/> .